Sources:<ref name = "DrugPoint">Truven Health Analytics, Inc. DrugPoint® System (Internet) [cited 2013 Sep 30]. Greenwood Village, CO: Thomsen Healthcare; 2013.</ref><ref name = "TGA">INVEGA® PRODUCT INFORMATION [Internet]. Janssen Pharmaceuticals; 2013 [cited 2013 Sep 30]. Available from: https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2013-PI-01421-1</ref><ref name = "BNF">Joint Formulary Committee. British National Formulary (BNF) 65. Pharmaceutical Pr; 2013.</ref><ref name = "Medscape">paliperidone (Rx) - Invega, Invega Sustenna [Internet]. Medscape Reference. [cited 2013 Sep 30]. Available from: http://reference.medscape.com/drug/invega-sustenna-paliperidone-342992#4</ref>

 


 
;Very Common (>10% incidence)

 
* Headache

 
* [[Tachycardia]]

 
* [[Somnolence]] (causes less sedation than most atypical antipsychotics<ref name = "Lancet" />)

 
* Insomnia

 
* [[Hyperprolactinaemia]] (seems to cause comparable prolactin elevation to its parent drug, [[risperidone]]<ref name = "Lancet">{{cite journal |last1=Leucht |first1=Stefan |last2=Cipriani |first2=Andrea |last3=Spineli |first3=Loukia |last4=Mavridis |first4=Dimitris |last5=Örey |first5=Deniz |last6=Richter |first6=Franziska |last7=Samara |first7=Myrto |last8=Barbui |first8=Corrado |last9=Engel |first9=Rolf R |last10=Geddes |first10=John R |last11=Kissling |first11=Werner |last12=Stapf |first12=Marko Paul |last13=Lässig |first13=Bettina |last14=Salanti |first14=Georgia |last15=Davis |first15=John M |title=Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis |journal=Lancet |volume=382 |issue=9896 |pages=951–62 |year=2013 |pmid=23810019 |doi=10.1016/S0140-6736(13)60733-3 }}</ref>)

 


 
;Common (1–10% incidence)

 
* Cough

 
* [[Extrapyramidal symptoms|Extrapyramidal side effects]] (EPSE; e.g. [[dystonia]], [[akathisia]], muscle rigidity, [[parkinsonism]]. It appears to produce similar EPSE to [[risperidone]], [[asenapine]] and [[ziprasidone]] and more EPSE than [[olanzapine]], [[clozapine]], [[aripiprazole]], [[quetiapine]], [[amisulpride]] and [[sertindole]]<ref name = "Lancet" />)

 
* [[Orthostatic hypotension]]

 
* Weight gain (tends to produce a moderate degree of weight gain, possibly related to its potent blockade of the 5-HT<sub>2C</sub> receptor)

 
* [[Long QT syndrome|QT interval prolongation]] (tends to produce less [[QT interval]] prolongation than most other atypical antipsychotics and approximately as much QT interval prolongation as [[aripiprazole]] and [[lurasidone]]<ref name = "Lancet" />)

 
* [[Common cold|Nasopharyngitis]]

 
* [[Anxiety]]

 
* Indigestion

 
* Constipation

 

